Kramer-Marek conducted photoimmunotherapy by conjugating an EGFR-specific affibody molecule to IR700, which generated ROS; induced ICD with the release of HMGB1, CRT, ATP, and HSP70/90; and promoted an anti-tumor immune response in a murine model [235]. This evidence concerns the gene CALR and neoplasm.